SCOPUS 정보 검색 플랫폼

Urology

Volumn 48, Issue 3, 1996, Pages 508-511

Inhibition of prostate cancer growth by 9-aminocamptothecin and estramustine

(3) Naik, Harmesh a Lehr, Jeff E a Pienta, Kenneth J a,b

a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL (United States)

b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 AMINOCAMPTOTHECIN; ESTRAMUSTINE;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL NUCLEUS MATRIX; CONTROLLED STUDY; DNA SYNTHESIS; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; RAT; TUMOR VOLUME;

EID: 0030249337 PISSN: 00904295 EISSN: None Source Type: Journal
DOI: 10.1016/S0090-4295(96)00201-4 Document Type: Article

Times cited : (8)

References (11)

1
- 0027532535
- Cytotoxic chemotherapy for advanced hormone resistant prostate cancer
- Yagoda A, and Petrylak D: Cytotoxic chemotherapy for advanced hormone resistant prostate cancer. Cancer 71: 1098-1109, 1993.
- (1993) Cancer , vol.71 , pp. 1098-1109
- Yagoda, A.¹ Petrylak, D.²

2
- 0024384664
- Cancer as a disease of DNA organization and dynamic cell structure
- Pienta KJ, Partin AW, and Coffey DS: Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res 49: 2525-2532, 1989.
- (1989) Cancer Res , vol.49 , pp. 2525-2532
- Pienta, K.J.¹ Partin, A.W.² Coffey, D.S.³

3
- 0027154852
- Inhibition of prostate cancer growth by estramustine and etoposide: Evidence for interaction at the nuclear matrix
- Pienta KJ, and Lehr JE: Inhibition of prostate cancer growth by estramustine and etoposide: evidence for interaction at the nuclear matrix. J Urol 149: 1622-1625, 1993.
- (1993) J Urol , vol.149 , pp. 1622-1625
- Pienta, K.J.¹ Lehr, J.E.²

4
- 0028104733
- Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate
- Pienta KJ, Redman BG, Hussain M, Cummings G, Esper PS, Appel C, and Flaherty LE: Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate. J Clin Oncol 12: 2005-2012, 1994.
- (1994) J Clin Oncol , vol.12 , pp. 2005-2012
- Pienta, K.J.¹ Redman, B.G.² Hussain, M.³ Cummings, G.⁴ Esper, P.S.⁵ Appel, C.⁶ Flaherty, L.E.⁷

5
- 0024324205
- On the mechanism of topoisomerase I inhibition by camptothecin: Evidence for binding to an enzyme-DNA complex
- Hertzberg RP, Carafana MJ, and Hecht SM: On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. Biochemistry 28: 4629-4638, 1989.
- (1989) Biochemistry , vol.28 , pp. 4629-4638
- Hertzberg, R.P.¹ Carafana, M.J.² Hecht, S.M.³

6
- 0024358188
- DNA topoisomerase I-targeted chemotherapy of human colon cancer in xenografts
- Giovanella BC, Stehlin JS, Wall ME, Wani MC, Nicholas AW, Liu LF, Silber R, and Potmesil M: DNA topoisomerase I-targeted chemotherapy of human colon cancer in xenografts. Science 246: 1046-1048, 1989.
- (1989) Science , vol.246 , pp. 1046-1048
- Giovanella, B.C.¹ Stehlin, J.S.² Wall, M.E.³ Wani, M.C.⁴ Nicholas, A.W.⁵ Liu, L.F.⁶ Silber, R.⁷ Potmesil, M.⁸

7
- 0027817002
- Efficacy of camptothecin congeners in the treatment of human breast carcinoma xenografts
- Pantazis P, Kozielski AJ, Vardeman DM, Petry ER, and Giovanella BC: Efficacy of camptothecin congeners in the treatment of human breast carcinoma xenografts. Oncol Res 5: 273-281, 1993.
- (1993) Oncol Res , vol.5 , pp. 273-281
- Pantazis, P.¹ Kozielski, A.J.² Vardeman, D.M.³ Petry, E.R.⁴ Giovanella, B.C.⁵

8
- 0026694680
- Complete inhibition of growth followed by death of human malignant melanoma cells in vitro and regression of human melanoma xenografts in immunodeficient mice induced by camptothecins
- Pantazis P, Hinz HR, Mendoza JT, Kozielski AJ, Williams LJ Jr, Stehlin JS Jr, and Giovanella BC: Complete inhibition of growth followed by death of human malignant melanoma cells in vitro and regression of human melanoma xenografts in immunodeficient mice induced by camptothecins. Cancer Res 52: 3980-3987, 1992.
- (1992) Cancer Res , vol.52 , pp. 3980-3987
- Pantazis, P.¹ Hinz, H.R.² Mendoza, J.T.³ Kozielski, A.J.⁴ Williams Jr., L.J.⁵ Stehlin Jr., J.S.⁶ Giovanella, B.C.⁷

9
- 0025115739
- Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction
- Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD, et al: Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87: 7160-7164, 1990.
- (1990) Proc Natl Acad Sci USA , vol.87 , pp. 7160-7164
- Noonan, K.E.¹ Beck, C.² Holzmayer, T.A.³ Chin, J.E.⁴ Wunder, J.S.⁵ Andrulis, I.L.⁶ Gazdar, A.F.⁷ Willman, C.L.⁸ Griffith, B.⁹ Von Hoff, D.D.¹⁰

10
- 0026146851
- Nuclear matrix targets for anticancer agents
- Fernandes DJ, and Catapano CV: Nuclear matrix targets for anticancer agents. Cancer Cells 3: 134-140, 1991.
- (1991) Cancer Cells , vol.3 , pp. 134-140
- Fernandes, D.J.¹ Catapano, C.V.²

11
- 0028104732
- Combination chemotherapy in advanced prostate cancer: A silk purse?
- Roth BJ: Combination chemotherapy in advanced prostate cancer: a silk purse? J Clin Oncol 12: 2001-2002, 1994.
- (1994) J Clin Oncol , vol.12 , pp. 2001-2002
- Roth, B.J.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.